Page 49 - Gurufocus Value News Today

Chief Scientific Officer Stephen Betz of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 3,000 shares of the company on January 10, 2024, according to a recent SEC Filing.

Michael Urban, the President of Americas at TD Synnex Corp, executed a sale of 5,000 shares of the company on January 11, 2024, according to a recent SEC filing.

Telekom Deutsche, a director and 10% owner of T-Mobile US Inc (NASDAQ:TMUS), sold 584,730 shares of the company on January 12, 2024, according to a recent SEC filing.

Gilead Sciences Inc (NASDAQ:GILD), a biopharmaceutical company that researches, develops, and commercializes drugs in areas such as HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions, has reported an insider sell according to a recent SEC filing.

George Hendren, SVP, COO of GMS Inc (NYSE:GMS), has sold 3,404 shares of the company on January 8, 2024, according to a recent SEC Filing.

Essential Properties Realty Trust Inc (NYSE:EPRT) President and CEO Peter Mavoides executed a sale of 23,112 shares of the company on January 8, 2024, according to a recent SEC Filing.

Sanjeev Aggarwal, PRESIDENT AND CEO of Everspin Technologies Inc (NASDAQ:MRAM), executed a sale of 15,588 shares in the company on January 5, 2024, according to a SEC Filing.

Brian Ratzan, a director at The Simply Good Foods Co, executed a sale of 30,768 shares in the company on January 4, 2024, according to a recent SEC Filing.

EVP and Chief Strategy Officer Christopher Rogers has sold 5,017 shares of PENN Entertainment Inc (NASDAQ:PENN) on January 3, 2024, according to a recent SEC Filing.

On January 4, 2024, EVP & GENERAL COUNSEL Paul Mahon executed a sale of 6,000 shares of United Therapeutics Corp (NASDAQ:UTHR), as reported in a recent SEC Filing.